Humira (adalimumab) has a half-life of about two weeks, meaning it takes roughly two weeks for half the drug to leave your body after your last injection. For the drug to be effectively cleared, you’re looking at about five half-lives, which works out to roughly 10 to 15 weeks (two to four months) after your final dose. That timeline can vary depending on your body and how long you’ve been taking the medication.
How the Two-Week Half-Life Works
A drug’s half-life tells you how long it takes for the concentration in your blood to drop by half. For Humira, the FDA lists a mean terminal half-life of approximately two weeks, with a range of 10 to 20 days across studies. That range matters because it means some people clear the drug noticeably faster or slower than average.
Here’s what the math looks like after your last injection, using the average 14-day half-life:
- 2 weeks: 50% of the drug remains
- 4 weeks: 25% remains
- 6 weeks: 12.5% remains
- 8 weeks: about 6% remains
- 10 weeks: about 3% remains
Pharmacologists generally consider a drug “out of your system” after five half-lives, when less than 3% remains. For Humira, that puts the full clearance window at roughly 10 to 14 weeks for most people. If your personal half-life is on the longer end (20 days), it could take closer to 15 weeks.
Why Clearance Time Varies Between People
Humira is a large protein molecule (a monoclonal antibody), and the body doesn’t process it the same way it handles a small-molecule pill. Your body’s clearance rate for adalimumab is approximately 12 milliliters per hour, but several factors can shift that number up or down.
Body weight and BMI are among the strongest influences. Larger body size generally means more tissue for the drug to distribute through, which can affect both how much drug circulates at any given time and how quickly levels drop. Gender, albumin levels in the blood, and the degree of underlying inflammation also play a role. People with more active disease tend to burn through the drug faster because the inflammatory proteins that Humira targets essentially “use up” the medication more quickly.
One of the most significant factors is whether your immune system has developed antibodies against the drug itself. These anti-drug antibodies can bind to Humira and accelerate its clearance from the body, sometimes dramatically shortening the time it remains effective. This is one reason some people lose response to Humira over time, and it also means the drug may leave their system faster than the standard two-week half-life would predict.
How Long Humira Shows Up on Blood Tests
If you’re getting therapeutic drug monitoring, blood tests can detect adalimumab in your serum for weeks after your last dose. These tests measure the actual drug concentration in your blood and are typically used to check whether you have enough medication circulating to control your condition. Given the two-week half-life, detectable levels generally persist for two to three months after the final injection, though this depends on the sensitivity of the test and how much drug had accumulated in your body during treatment.
If your doctor orders an adalimumab level along with anti-drug antibodies (a common combination), the results can also reveal whether your body has been mounting an immune response against the medication. Low drug levels paired with high antibody levels suggest your body was clearing the drug faster than expected.
Stopping Humira Before Surgery
One of the most common reasons people want to know how long Humira stays in the system is upcoming surgery. Because Humira suppresses part of the immune system, it can increase the risk of post-surgical infections if it’s still active in your body when you go under the knife.
The typical approach, as recommended by specialists at Johns Hopkins Arthritis Center, is to skip the dose before surgery so that you have at least two weeks without Humira before the procedure. After surgery, patients generally wait another two weeks before restarting, assuming the surgical wound is healing normally and there’s no sign of infection. Your surgeon and the doctor who prescribes your Humira will coordinate on the exact timing, since the right window depends on both the type of surgery and how well your underlying condition is controlled.
What Happens as Humira Leaves Your Body
As drug levels decline, the immune suppression that Humira provides gradually fades. For people taking Humira for conditions like rheumatoid arthritis, Crohn’s disease, or psoriasis, this means symptoms can return as the drug clears. The timeline for symptom recurrence doesn’t always match the pharmacokinetic clearance window perfectly. Some people notice a flare within a few weeks of their last dose, while others stay stable for a couple of months before symptoms creep back.
If you’ve been on Humira for a long time, the drug reaches what’s called a steady state in your blood, where each new injection tops off the level before it falls too far. Once you stop injecting, it takes longer to clear from this accumulated baseline than it would after a single dose. This is another reason the practical clearance window can stretch toward the longer end of estimates for long-term users.